The role of botulinum toxin in the management of head and neck cancer patients

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 15, Issue 2, 2007, Pages 112-116

  Laskawi, Rainer ^a   Ellies, Maik ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Botulinum toxin; Head and neck cancer

Indexed keywords

BOTULINUM TOXIN A;

BLEPHAROSPASM; CANCER PATIENT; DRUG EFFICACY; FACIAL NERVE PARALYSIS; HEAD AND NECK CANCER; HEMIFACIAL SPASM; HUMAN; HYPERSALIVATION; LACRIMATION DISORDER; LARYNGECTOMY; MOTOR DYSFUNCTION; NERVE REGENERATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; SPEECH DISORDER; SWEAT GLAND DISEASE; SYNKINESIS; TREATMENT PLANNING; UNSPECIFIED SIDE EFFECT;

BOTULINUM TOXIN TYPE A; DYSKINESIAS; FACIAL NERVE INJURIES; FACIAL PARALYSIS; HEAD AND NECK NEOPLASMS; HUMANS; LACRIMAL APPARATUS DISEASES; LARYNGECTOMY; MUSCLE SPASTICITY; NEUROMUSCULAR AGENTS; SIALORRHEA; SPEECH DISORDERS; SWEATING, GUSTATORY;

EID: 34247102191     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOO.0b013e328014731c     Document Type: Review

References (20)

1. Cheng CM, Chen JS, Patel RP. Unlabeled uses of botulinum toxins: a review, part 1. Am J Health Syst Pharm 2006; 15:145-152. This paper gives an excellent review about the spectrum of indications, including the side effects of different treatment options.
2. Cheng CM, Chen JS, Patel RP. Unlabeled uses of botulinum toxins: a review, part 2. Am J Health Syst Pharm 2006; 15:225-232. The second part of an excellent review about the spectrum of indications, including the side effects of different treatment options.
3. Laskawi R, Rohrbach S. Surgical and conservative methods for restoring impaired motor function: facial nerve, spinal accessory nerve, hypoglossal nerve (not including vagal nerve or swallowing). GMS Curr Top Otorhinolaryngol Head Neck Surg 2005; 4:Doc10.
4. Laskawi R, Damenz W, Roggenkämper P, Baetz A. Botulinum toxin treatment in patients with facial synkinesis. Eur Arch Otorhinolaryngol 1994; suppl 1:195-199.
5. Roggenkämper P, Laskawi R, Damenz W, et al. Orbicular synkinesis after facial paralysis: treatment with botulinum toxin. Documenta Ophthalmol 1994; 86:395-402.
6. Laskawi R. Combination of hypoglossal-facial nerve anastomosis and botulinum toxin injections to optimize mimic rehabilitation following removal of acoustic neurinomas. Plast Reconstr Surg 1997; 99:1006-1011.
7. Laskawi R, Rohrbach S, Rödel R. Surgical and nonsurgical treatment options in patients with movement disorders of the platysma. J Oral Maxillofac Surg 2002; 60:157-162.
8. Chao SS, Graham SM, Hoffman HT. Management of pharyngoesophageal spasm with Botox. Otolaryngol Clin North Am 2004; 37:559-566.
9. Ellies M, Laskawi R, Rohrbach-Volland S, Arglebe C. Up-to-date report of botulinum toxin therapy in patients with drooling caused by different etiologies. J Oral Maxillofac Surg 2003; 61:454-457.
10. Ellies M, Gottstein U, Rohrbach-Volland S, et al. Reduction of salivary flow with botulinum toxin: extended report on 33 patients with drooling, salivary fistulas and sialadenitis. Laryngoscope 2004; 114:1856-1860.
11. Laskawi R, Ellies M, Rödel R, Schoenebeck C. Gustatory sweating: clinical implications and etiologic aspects. J Oral Maxillofac Surg 1999; 57:642-648.
12. Laskawi R, Rohrbach S. Frey's syndrome: treatment with botulinum toxin. Curr Probl Dermatol 2002; 30:170-177.
13. Drobik C, Laskawi R. Frey's syndrome: treatment with botulinum toxin [in German]. HNO Aktuell 1994; 2:142-144.
14. Laskawi R, Drobik C, Schönebeck C. Up-to-date report of botulinum toxin treatment in patients with gustatory sweating. Laryngoscope 1998; 108:381-384.
15. Laskawi R, Rohrbach S. Treatment of gustatory sweating with botulinum toxin: special aspects. ORL J Otorhinolaryngol Relat Spec 2001; 63:294-297.
16. Nolte D, Gollmitzer I, Loeffelbein DJ, et al. Botulinum toxin in the treatment of Frey's syndrome [in German]. Mund Kiefer GesichtsChir 2004; 8:369-375.
17. Glaser DA. The use of botulinum toxins to treat hyperhidrosis and gustatory sweating syndrome. Neurotox Res 2006; 9:173-177. This paper gives an excellent review about the use of BTA in hyperhidrosis and gustatory sweating.
18. Meyer M. Diseases of the lacrimal gland [in German]. In: Laskawi R, Roggenkämper P (eds.). Botulinumtoxintherapie im Kopf-Hals-Bereich. München: Urban und Vogel; 2004. pp. 313-322.
19. Riemann R, Pfenningsdorf S, Riemann E, Naumann M. Successful treatment of crocodile tears by injection of botulinum toxin into lacrimal gland: a case report. Ophthalmology 1999; 106:2322-2324.
20. Whittaker KW, Matthews BN, Fitt AW, Sandramouli S. The use of botulinum toxin A in the treatment of functional epiphora. Orbit 2003; 22:193-198.